Real-life evidence of encorafenib plus binimetinib in patients with unresectable advanced or metastatic BRAFV600-mutant melanoma in Spain: the BECARE (GEM-2002) trial

Colaboración

Año: 2025

Soria, A; Mauriño, PS; Domingo, JJS; Galindo, RG; Sequero, S; Sanz, LG; Crespo, G; Díaz-Beveridge, R; Puértolas, T; López, P; Rodríguez, JF; Castro, RL; Aguayo, C; Valdivia, J; Cunquero-Tomás, AJ; Benítez, G; de Miguel, PA; Espinosa, E; Muñoz-Couselo, E; Campos, B; Sánchez, LG; Cerezuela-Fuentes, P

Título: FRONTIERS IN ONCOLOGY

• Q2